| | The NHS National Services Scotland has awarded the contract for a National
Chemotherapy ePrescribing and administration system (CEPAS) for NHSScotland to
ChemoCare® from CIS Oncology Ltd.
The contract provides a National Framework whereby each of the Regional Cancer
Networks, West of Scotland Cancer Network (WoSCAN), South East Scotland Cancer
Network (SCAN) and North of Scotland Cancer Network (NOSCAN) can enter into
individual Call Off Contracts detailing the software and services they require to support
their patients and services.
The contract award further demonstrates Scotland’s commitment to cancer, and was
highlighted as being important in supporting the safe delivery of chemotherapy within
Better Cancer Care, An Action Plan published in October 2008. The procurement was
initiated in September 2006 and involved assessment of functional, technical and
performance requirements for the Software and Services.
ChemoCare® will provide safe chemotherapy prescribing and administration and gives
each patient a single lifelong electronic chemotherapy record that is accessible to
designated members of the multidisciplinary team across the pathways of care and from
multiple geographical points of service delivery.
The Call Off Contract for WoSCAN has also been agreed and implementation is
underway. The system is being hosted at the Beatson West of Scotland Cancer Centre
in Glasgow and will be implemented across a further 12 hospitals across the region
starting with the New Victoria Ambulatory Care Hospital.
Dr Bob Masterton, Regional Lead Cancer Clinician welcomed this development stating
that “working in partnership with CIS Oncology WOSCAN will be able to deliver real
improvements in how we provide chemotherapy services across the region. The
implementation of ChemoCare supports one of our key goals to safely deliver care as
close to home as possible. This development will help us manage the introduction of
new cancer medicines across the west of Scotland, monitor the uptake of cancer
medicines more effectively and better understand clinical outcomes. We don’t
underestimate the challenges that lie ahead in implementing what will be the largest
networked solution in the UK and look forward to working with CIS to deliver the benefits
that this system will bring for patients in the west of Scotland.”
CIS Oncology is proud to be the leading supplier of chemotherapy prescribing and
management systems in the UK with over fifteen years experience in successfully
delivering solutions to the NHS. Tony Pegg, Chief Executive of CIS Oncology added,
“We are delighted to be working in partnership with NHSScotland to deliver ChemoCare©
on this national project. With our extensive experience of what is required to
successfully deliver and support oncology systems throughout the UK, we believe we
are ideally placed to support all three regional networks on the achievement of the
CEPAS goals”.
- Ends -
NOTES TO EDITORS:
For press enquiries, please contact:
Valerie Lee
Sales Director
CIS Oncology Ltd
Unit 4 Channel Wharf
Old Channel Road
Belfast BT3 9DE
Tel: +44 (0)2890 735950
Mobile: 07717 794340
Email: valerie.lee@cis-healthcare.com
About CIS Oncology:
CIS Oncology is a leading specialist software company which provides software products and support specifically relating
to the complex needs of health professionals within the field of chemotherapy oncology healthcare market.
CIS Oncology is part of the larger CIS Healthcare Ltd organisation. CIS Healthcare Ltd is a growing provider of Healthcare IT systems to the NHS and internationally. Today the company has a turnover in excess of £4m with offices in
London, Aalborg, Belfast, Hamburg, Cwmbran, Reykjavik and Tilburg and comprises four businesses operating in four sectors of specialty which are:
CIS Oncology: The leading supplier of chemotherapy prescribing and management systems in the UK and currently
implemented in over 60 hospitals with over fifteen years experience in successfully delivering solutions to the NHS;
Theriak Medication Management (TMM): State-of-the-art drug prescribing, dispensing and bed side verification
software; built to support the complete closed loop of medication management in the hospital. In excess of 1000
users across Holland, Iceland, Sweden, Denmark and Germany;
CIS Orion Imaging: Diabetic Retinopathy screening system in use in over 35 screening programs in England:
CIS GmbH, CYPRO: Chemotherapy drug preparation management system with over 500 users in cancer treatment
centres, primarily in Germany. |